Plantible | $30,000,000 | (Nov 19, 2024)
Theranautilus | $1,200,000 | (Nov 19, 2024)
Bluespine | $7,200,000 | (Nov 19, 2024)
Certified by Founder
Lodge
Terray Therapeutics
start up
United States
- Pasadena, California
- 10/11/2023
- Unknown
- Undisclosed Amount
Terray is a biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small molecule therapeutics. We explore molecules and targets broadly and deeply with a sophisticated integration of ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology. Everything the company does is grounded in an iterative approach, producing massive amounts of precise, purpose-built data that gets increasingly valuable with each cycle of design and experimentation. The company’s platform uniquely blends experimentation and computation to improve the cost, speed, and success rate of small molecule drug discovery and development.
- Industry Biotechnology Research
- Website https://www.terraytx.com/
- LinkedIn https://www.linkedin.com/company/terray-therapeutics/about/
Zenflow, Inc. | $24,000,000 | (Nov 19, 2024)
Coopah | $1,901,280 | (Nov 19, 2024)
Revisto | $4,000,000 | (Nov 19, 2024)
ChapsVision | $90,000,000 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
IonKraft | $3,706,797 | (Nov 19, 2024)
ANELLO Photonics | Undisclosed Amount | (Nov 19, 2024)
Influur | $10,000,000 | (Nov 15, 2024)
Naturbeads | $9,890,632 | (Nov 15, 2024)